EuroMAbNet: European Monoclonal Antibodies NetworkEuroMAbNet. European Monoclonal Antibodies Network homepage

Menu

Members

Ilija Brizić

Name of the laboratory

CapRi: Center for monoclonal antibody production
Center for Proteomics
Faculty of Medicine
University of Rijeka
B. Branchetta 20, 51 000 Rijeka, Croatia
+385 51 651 260 / 651 250

Members of the laboratory

Members: Center for Proteomics
Team Leader
Ilija Brizić ilija.brizic@medri.uniri.hr
Research Personnel
Stipan Jonjić stipan.jonjic@medri.uniri.hr
Astrid Krmpotić astrid.krmpotic@medri.uniri.hr
Tihana Lenac Roviš tihana.lenac@medri.uniri.hr
Vanda Juranić Lisnić vanda.juranic@medri.uniri.hr
Berislav Lisnić berislav.lisnic@medri.uniri.hr
Maja Cokarić Brdovčak maja.cokaric@medri.uniri.hr
Paola Kučan Brlić paola.kucan@medri.uniri.hr
Ivana Bertović ibertovic@medri.uniri.hr
Fran Krstanović fran.krstanovic@medri.uniri.hr
Valentina Hribljan valentina.hribljan@medri.uniri.hr
Jelena Materljan Franki jelena.materljan@uniri.hr
Marija Mazor marija.mazor@medri.uniri.hr
Marko Šustić marko.sustic@medri.uniri.hr
Jelena Železnjak jelena.zeleznjak@medri.uniri.hr
PhD Students
Ema Bellulovich ema.bellulovich@medri.uniri.hr
Martina Brnjić martina.brnjic@medri.uniri.hr
Magdalena Medved magdalena.medved@medri.uniri.hr
Andrea Mihalić andrea.mihalic@medri.uniri.hr
Lucija Šakota lucija.sakota@medri.uniri.hr
Iva Vladić iva.vladic@medri.uniri.hr
Research Associates
Hrvoje Šimić hrvoje.simic@medri.uniri.hr
Marina Čunko marina.cunko@medri.uniri.hr
Laboratory Engineers
Karmela Miklić karmela.miklic@medri.uniri.hr
Suzana Malić suzana.malic@medri.uniri.hr
Leonarda Mikša leonarda.miksa@medri.uniri.hr
Project Management Personnel
Antonija Šarlija antonija.sarlija@medri.uniri.hr
Cristina Paulović cristina.paulovic@medri.uniri.hr
Irena Čeple Nikolić irena.ceple.nikolic@uniri.hr
Antonija Radić antonija.radic@medri.uniri.hr

Laboratory activity

The Center for Proteomics, founded in 2006 at the University of Rijeka, Faculty of Medicine, specializes in high-throughput development of monoclonal antibodies (mAbs) for research and therapeutic applications. The Center maintains a repository of several hundred hybridoma cell lines that produce mAbs targeting a broad array of different proteins. Over the past years, the Center has participated in numerous collaborative projects with research institutes, universities, and biotechnology small- and medium-enterprises across Southeast Europe, the European Union, and the United States, focusing on the production and detailed characterization of mAbs for experimental and pre-clinical studies. Antibodies generated by the Center have contributed to investigations that have been published in leading peer-reviewed scientific journals.

Research activities

We conduct multidisciplinary research on viral immunology, innate and adaptive immune responses, and development of vaccines and biological therapies. Our research efforts focus on viral immunosubversion mechanisms, tissue-specific immune responses in congenital and perinatal infections affecting the central nervous system, reproductive tract, adrenal glands, lungs, and heart, the creation of novel recombinant vaccine vectors, the immunometabolic aspects of viral pathogenesis, and the immune reactions to emerging viruses. In addition, we are dedicated to the development of cutting-edge immunotherapies for cancer treatment.

Techniques available

  • Expression and purification of recombinant proteins
  • Production of murine mAbs
  • mAb purification (HPLC, 5mg scale, adaptation to serum-free media)
  • mAb fragmentation
  • Western blot, immunoprecipitation, ELISA, flow cytometry, laser scanning, confocal microscopy, immunohistochemistry
  • Mycoplasma testing

Publications (2021-present)

  • Cokarić Brdovčak M, Materljan Franki J, Šustić M, Miklić K, Medved M, Gaćina L, Ružić T, Jonjić S, Brizić I, Krmpotić A. Cytomegalovirus-Based Viral Vectors Elicit Robust Systemic and Tissue-Resident Immune Response Against SARS-CoV-2 Antigens. Eur J Immunol 56, e70146. 2026.
  • Kučan Brlić P, Bellulovich E, Golemac M, Jakšić A, Markić D, Miklić K, Malić S, Babarović E, Đorđević G, Šupak Smolčić V, Lisnić B, Tsukerman P, Cinamon G, Jonjić S, Lenac Roviš T. High PVR protein expression marks clear cell renal cell carcinoma with metastatic spread. Front Immunol Volume 17 - 2026.
  • Cramer P, Neys SFH, Fiedler M, Lorenzetti R, Reinhard H, Janowska I, Staniek J, Kohl AK, Hadlova P, Huber M, Plachter B, Read C, Falcone V, von Einem J, Hoffmann K, Lenac Rovis T, Jonjic S, Kolb P, Rizzi M, Hengel H. A viral glycoprotein targets IgG. EMBO Mol Med. 2026.
  • Krstanović F, Mihalić A, Rashidi AS, Sitnik KM, Ruzsics Z, Čičin-Šain L, Verjans GMGM, Jonjić S, Brizić I. Neuron-restricted cytomegalovirus latency in the central nervous system regulated by CD4. J Neuroinflammation 22: 95. 2025.
  • Krapić M, Kavazović I, Mikašinović S, Mladenić K, Krstanović F, Seyhan G, Helmrath S, Camerini E, Brizić I, Peters FS, Schmidt-Supprian M, Polić B, Turk Wensveen T, Wensveen FM. NK cell-derived IFNγ mobilizes free fatty acids from adipose tissue to promote early B cell activation during viral infection. Nat Metab 7: 985-1003. 2025.
  • Sparano C, Solís-Sayago D, Zangger NS, Rindlisbacher L, Van Hove H, Vermeer M, Westermann F, Mussak C, Rallo E, Dergun S, Litscher G, Xu Y, Bijnen M, Friedrich C, Greter M, Juranić Lisnić V, Becher B, Gasteiger G, Oxenius A, Tugues S. Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells. J Exp Med 222. 2025.
  • Jonjić A, Dolanc I, Slivšek G, Bočkor L, Tarle M, Mustapić S, Kmet M, Orehovec B, Kučan Brlić P, Cokarić Brdovčak M, Obad A, Walenta M, Dražić I, Bilić-Zulle L, Lukšić I, Bulić N, Goessler W, Jonjić S, Čoklo M, Žučko J. Relationship Between Gut Microbiota and the Clinical Course of COVID-19 Disease. Viruses 17. 2025.
  • de Lorenzo V, Rainey PB, Williams P, Karahan ZC, López-García P, Jonjić S, Timmis KN. Storm over science: predatory practices and the fight for research reliability. Microlife 6: uqaf029. 2025.
  • Timmis K, Williams P, Karahan ZC, López-García P, Rainey P, Chavarria M, Greening C, Steward K, Hallsworth JE, Pereira CS, Giraldo R, Verstraete W, Jonjić S, Ramos JL, Nunes O, Ventosa A, Armstrong R, Sessitsch A, Ron E, Wang H. Journals Operating Predatory Practices Are Systematically Eroding the Science Ethos: A Gate and Code Strategy to Minimise Their Operating Space and Restore Research Best Practice. Microb Biotechnol 18: e70180. 2025.
  • Rainey PB, López-García P, Karahan ZC, Williams P, Jonjić S, Timmis KN. Editorial: society journals matter-supporting science through renewed commitment. Microlife 6, uqaf032. 2025.
  • Mikulak J, Supino D, Marzano P, Terzoli S, Carriero R, Cazzetta V, Piazza R, Bruni E, Kunderfranco P, Donato A, Mapelli SN, Garuti R, Carnevale S, Scavello F, Magrini E, Zeleznjak J, Peano C, Donadon M, Costa G, Torzilli G, Mantovani A, Garlanda C, Mavilio D. Tissue-specific antitumor NK cell subsets identified in colorectal cancer liver metastases express candidate therapeutic targets. J Clin Invest 135. 2025.
  • Tillmanns J, Wangen C, Geiger P, Häge S, Lenac Roviš T, Arnold P, Sticht H, Marschall M. The phospho-dynamics of cytomegalovirus capsid interaction, with its protein kinase and nuclear egress complex, provide an antiviral targeting concept. Antiviral Res 246: 106335. 2025.
  • Viduka I, Štimac I, Jurić SL, Gulić T, Lisnić B, Zagorac GB, Lučin HM, Lučin P. Contribution of Sorting Nexin 3 in the Cytomegalovirus Assembly. Biomedicines 13. 2025.
  • Bentley K, Statkute E, Murrell I, Fielding CA, Antrobus R, Preston H, Kerr-Jones L, Cochrane D, Brizic I, Lehner PJ, Wilkinson GWG, Wang ECY, Graham SC, Weekes MP, Stanton RJ. Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity. Proc Natl Acad Sci U S A 122: e2425622122. 2025.
  • Moda F, Ferracin C, Dellarole IL, Bistaffa E, De Luca CMG, Zattoni M, Legari DG, Nikolic L, Burato A, Brce M, Bufano G, Bacınoğlu MB, Cazzaniga FA, Rovis TL, Legname G. Exploring the impact of SerpinA3n deficiency on prion strains propagation. Neurobiol Dis 212: 106973. 2025.
  • Krstanović F, Mihalić A, Šakota L, Lisnić B, Jonjić S, Brizić I. Susceptibility of Mouse Brain to MCMV Infection and Neuroinflammation During Ontogeny. Pathogens 13. 2024.
  • Mihalić A, Železnjak J, Lisnić B, Jonjić S, Juranić Lisnić V, Brizić I. Immune surveillance of cytomegalovirus in tissues. Cell Mol Immunol 21: 959-981. 2024.
  • Kveštak D, Mihalić A, Jonjić S, Brizić I. Innate lymphoid cells in neuroinflammation. Front Cell Neurosci 18: 1364485. 2024.
  • Karner D, Kvestak D, Kucan Brlic P, Cokaric Brdovcak M, Lisnic B, Brizic I, Juranic Lisnic V, Golemac M, Tomac J, Krmpotic A, Karkeni E, Libri V, Mella S, Legname G, Altmeppen HC, Hasan M, Jonjic S, Lenac Rovis T. Prion protein alters viral control and enhances pathology after perinatal cytomegalovirus infection. Nat Commun 15: 7754. 2024.
  • Pietri GP, Bertuzzi S, Karnicar K, Unione L, Lisnic B, Malic S, Miklic K, Novak M, Calloni I, Santini L, Usenik A, Romano MR, Adamo R, Jonjic S, Turk D, Jiménez-Barbero J, Lenac Rovis T. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design. Carbohydr Polym 341: 122349. 2024.
  • Karner D, Kvestak D, Lisnic B, Cokaric Brdovcak M, Juranic Lisnic V, Kucan Brlic P, Hasan M, Lenac Rovis T. Comprehensive Analysis of Soluble Mediator Profiles in Congenital CMV Infection Using an MCMV Model. Viruses 16. 2024.
  • Jonjić S. Tissue-specific antiviral immunity. Cell Mol Immunol 21: 941-942. 2024.
  • Šestan M, Mikašinović S, Benić A, Wueest S, Dimitropoulos C, Mladenić K, Krapić M, Hiršl L, Glantzspiegel Y, Rasteiro A, Aliseychik M, Cekinović Grbeša Đ, Turk Wensveen T, Babić M, Gat-Viks I, Veiga-Fernandes H, Konrad D, Wensveen FM, Polić B. An IFNγ-dependent immune-endocrine circuit lowers blood glucose to potentiate the innate antiviral immune response. Nat Immunol 25: 981-993. 2024.
  • Biniaris-Georgallis SI, Aschman T, Stergioula K, Schreiber F, Jafari V, Taranko A, Karmalkar T, Kasapi A, Lenac Rovis T, Jelencic V, Bejarano DA, Fabry L, Papacharalampous M, Mattiola I, Molgora M, Hou J, Hublitz KW, Heinrich F, Guerra GM, Durek P, Patone G, Lindberg EL, Maatz H, Hölsken O, Krönke G, Mortha A, Voll RE, Clarke AJ, Hauser AE, Colonna M, Thurley K, Schlitzer A, Schneider C, Stamatiades EG, Mashreghi MF, Jonjic S, Hübner N, Diefenbach A, Kanda M, Triantafyllopoulou A. Amplification of autoimmune organ damage by NKp46-activated ILC1s. Nature 634: 952-960. 2024.
  • Metzdorf K, Jacobsen H, Kim Y, Teixeira Alves LG, Kulkarni U, Brdovčak MC, Materljan J, Eschke K, Chaudhry MZ, Hoffmann M, Bertoglio F, Ruschig M, Hust M, Šustić M, Krmpotić A, Jonjić S, Widera M, Ciesek S, Pöhlmann S, Landthaler M, Čičin-Šain L. A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants. Front Immunol 15: 1383086. 2024.
  • Maaß H, Ynga-Durand M, Milošević M, Krstanović F, Matešić MP, Žuža I, Jonjić S, Brizić I, Šustić A, Bloos F, Protić A, Čičin-Šain L, Group SCCT. Serum cytokine dysregulation signatures associated with COVID-19 outcomes in high mortality intensive care unit cohorts across pandemic waves and variants. Sci Rep 14: 13605. 2024.
  • Šušak B, Dalmatin-Dragišić M, Laura L, Mikulić V, Nakić K, Mikulić I, Brizić I, Arapović J, Arapović M. Excretion of SARS-CoV-2 RNA in feces has no prognostic benefit in the outcome of COVID-19: A clinical and immunological study. Biomol Biomed 24: 1016-1027. 2024.
  • Štimac I, Marcelić M, Radić B, Viduka I, Blagojević Zagorac G, Lukanović Jurić S, Rožmanić C, Messerle M, Brizić I, Lučin P, Mahmutefendić Lučin H. SNX27:Retromer:ESCPE-1-mediated early endosomal tubulation impacts cytomegalovirus replication. Front Cell Infect Microbiol 14: 1399761. 2024.
  • Sung CYW, Li M, Jonjic S, Sanchez V, Britt WJ. Cytomegalovirus infection lengthens the cell cycle of granule cell precursors during postnatal cerebellar development. JCI Insight 9. 2024.
  • Mahmutefendić Lučin H, Štimac I, Marcelić M, Skočaj M, Lisnić B, Omerović A, Viduka I, Radić B, Karleuša L, Blagojević Zagorac G, Deželjin M, Jurak Begonja A, Lučin P. Rab10-associated tubulation as an early marker for biogenesis of the assembly compartment in cytomegalovirus-infected cells. Front Cell Dev Biol 12: 1517236. 2024.
  • Wild M, Karner D, Eickhoff J, Wagner S, Kicuntod J, Chang W, Barry P, Jonjić S, Lenac Roviš T, Marschall M. Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers. Pharmaceutics 15(12), 2680. 2023.
  • Sitnik KM, Krstanović F, Gödecke N, Rand U, Kubsch T, Maaß H, Kim Y, Brizić I, Čičin-Šain L. Fibroblasts are a site of murine cytomegalovirus lytic replication and Stat1-dependent latent persistence in vivo. Nat Commun 14(1):3087. 2023.
  • Rožmanić C, Lisnić B, Pribanić Matešić M, Mihalić A, Hiršl L, Park E, Lesac Brizić A, Indenbirken D, Viduka I, Šantić M, Adler B, Yokoyama WM, Krmpotić A, Juranić Lisnić V, Jonjić S, Brizić I. Perinatal murine cytomegalovirus infection reshapes the transcriptional profile and functionality of NK cells. Nat Commun 14(1):6412. 2023.
  • Marinović S, Lenartić M, Mladenić K, Šestan M, Kavazović I, Benić A, Krapić M, Rindlisbacher L, Cokarić Brdovčak M, Sparano C, Litscher G, Turk Wensween T, Mikolašević I, Fučkar Čupić D, Bilić-Zulle L, Steinle A, Waisman A, Hayday A, Tugues S, Becher B, Polić B, Wensween F. NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis. Sci Immunol 8(87):eadd1599. 2023.
  • Le-Trilling VTK, Jagnjić A, Brizić I, Eilbrecht M, Wohlgemuth K, Rožmanić C, Herdman A, Hoffmann K, Westendorf AM, Hengel H, Jonjić S, Trilling M. Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus. NPJ Vaccines 8(1):8. 2023.
  • Eletreby M, Thiessen L, Prager A, Brizic I, Materljan J, Kubic L, Jäger K, Jurinović K, Jerak J, Krey K, Adler B. Dissecting the cytomegalovirus CC chemokine: Chemokine activity and gHgLchemokine-dependent cell tropism are independent players in CMV infection. PLoS Pathog 19(12):e1011793. 2023.
  • Worboys JD, Vowell KN, Hare RK, Ambrose AR, Bertuzzi M, Conner MA, Patel FP, Zammit WH, Gali-Moya J, Hazime KS, Jones KL, Rey C, Jonjic S, Rovis TL, Tannahill GM, Cruz De Matos GDS, Waight JD, Davis DM. TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. Nat Commun 18;14(1):5016. 2023.
  • Rešetar Maslov D, Thomas FC, Beletić A, Kuleš J, Rubić I, Benić M, Bačić G, Macesic N, Eraghi V, Farkaš V, Lenac Roviš T, Lisnić B, Žubčić D, Potočnjak D, Mrljak M. Distinguishing Natural Infections of the Bovine Mammary Gland by Staphylococcus from Streptococcus spp. Using Quantitative Milk Proteomics. Animals 13(11):1829. 2023.
  • Khaleafi R, Zeleznjak J, Cordela S, Drucker A, Lenac Rovis T, Jonjic S, Bar-On Y. Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality. Front Immunol. 2023.
  • Jurak I, Cokarić Brdovčak M, Djaković L, Bertović I, Knežević K, Lončarić M, Jurak Begonja A, Malatesti N. Photodynamic Inhibition of Herpes Simplex Virus 1 Infection by Tricationic Amphiphilic Porphyrin with a Long Alkyl Chain. Pharmaceutics 15(3):956. 2023.
  • Herb S, Zeleznjak J, Hennig T, L'Hernault A, Lodha M, Jürges C, Trsan T, Juranic Lisnic V, Jonjic S, Erhard F, Krmpotic A, Dölken L. Two murine cytomegalovirus microRNAs target the major viral immediate early 3 gene. J Gen Virol 103(11). 2022.
  • Schubert M, Bertoglio F, Steinke S, Heine PA, Ynga-Durand MA, Maass H, Sammartino JC, Cassaniti I, Zuo F, Du L, Korn J, Milošević M, Wenzel EV, Krstanović F, Polten S, Pribanić-Matešić M, Brizić I, Baldanti F, Hammarström L, Dübel S, Šustić A, Marcotte H, Strengert M, Protić A, Piralla A, Pan-Hammarström Q, Čičin-Šain L, Hust M. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant. BMC Med 20(1):102. 2022.
  • Brlić PK, Pavletić M, Lerga M, Krstanović F, Matešić MP, Miklić K, Malić S, Mikša L, Pajcur M, Peruč D, Schubert M, Bertoglio F, Arapović J, Protić A, Šustić A, Milošević M, Šain LČ, Jonjić S, Lisnić VJ, Brizić I. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study. Viruses 14(9):1966. 2022.
  • Brizić I, Lisnić B, Krstanović F, Brune W, Hengel H, Jonjić S. Mouse Models for Cytomegalovirus Infections in Newborns and Adults. Current Protocols 2(9):e537. 2022.
  • Kučan Brlić P, Brizić I. Taking on SARS-CoV-2. eLife 11:e80552. 2022.
  • Ynga-Durand M, Maaß H, Milošević M, Krstanović F, Pribanić Matešić M, Jonjić S, Protić A, Brizić I, Šustić A, Čičin-Šain L. SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes. Viruses 14;14(6):1292. 2022.
  • Zaffran I, Landolina N, Gaur P, Rovis TL, Stipan J, Mandelboim O, Singer BB, Levi-Schaffer F. Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Cancer Gene Therapy 29(11):1676-1685. 2022.
  • Cokaric Brdovcak M, Materljan J, Sustic M, Ravlic S, Ruzic T, Lisnic B, Miklic K, Brizic I, Pribanic Matesic M, Juranic Lisnic V, Halassy B, Roncevic D, Knezevic Z, Stefan L, Bertoglio F, Schubert M, Cicin-Sain L, Markotic A, Jonjic S, Krmpotic A. ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination. Eur J Immunol 52(6):936-945. 2022.
  • Pribanic Matesic M, Kucan Brlic P, Lenac Rovis T, Macak Safranko Z, Chaouat AE, Miklic K, Malic S, Ivankovic N, Schubert M, Bertoglio F, Markotic A, Mandelboim O, Jonjic S, Brizic I. Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins. Viruses 21;14(2):443. 2022.
  • Kim Y, Zheng X, Eschke K, Chaudhry MZ, Bertoglio F, Tomic A, Krmpotic A, Hoffmann M, Bar-On Y, Boehme J, Bruder D, Ebensen T, Brunotte L, Ludwig S, Messerle M, Guzman C, Mandelboim O, Hust M, Pohlmann S, Jonjic S, Cicin-Sain L. MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination. Cell Mol Immunol 19(2):234-244. 2022.
  • Angulo G, Zeleznjak J, Martínez-Vicente P, Puñet-Ortiz J, Hengel H, Messerle M, Oxenius A, Jonjic S, Krmpotic A, Engel P, Angulo A. Cytomegalovirus restricts ICOSL expression on antigen presenting cells disabling T cell co-stimulation and contributing to immune evasion. Elife 10:e59350. 2021.
  • Kveštak D, Juranić Lisnić V, Lisnić B, Tomac J, Golemac M, Brizić I, Indenbirken D, Cokarić Brdovčak M, Bernardini G, Krstanović F, Rožmanić C, Grundhoff A, Krmpotić A, Britt WJ, Jonjić S. NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection. J Exp Med 3;218(5):e20201503. 2021.
  • Lisnić B, Tomac J, Cekinović D, Jonjić S, Juranić Lisnić V. Rodent Models of Congenital Cytomegalovirus Infection. Methods Mol Biol 2244:365-401. 2021.
  • Tomac J, Mazor M, Lisnić B, Golemac M, Kveštak D, Bralić M, Bilić Zulle L, Brinkmann MM, Dölken L, Reinert LS, Paludan SR, Krmpotić A, Jonjić S, Juranić Lisnić V. Viral infection of the ovaries compromises pregnancy and reveals innate immune mechanisms protecting fertility. Immunity S1074-7613(21)00182-5, 54, 1-16. 2021.
  • Strazic Geljic I, Kucan Brlic P, Musak L, Karner D, Ambriović-Ristov A, Jonjic S, Schu P, Lenac Rovis T. Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species. Int J Mol Sci 5274. 2021.
  • Šustić M, Cokarić Brdovčak M, Lisnić B, Materljan J, Juranić Lisnić V, Rožmanić C, Indenbirken D, Hiršl L, Busch DH, Brizić I, Krmpotić A, Jonjić S. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features. Front Immunol 12. 2021.
  • Krstanović F, Britt WJ, Jonjić S, Brizić I. Cytomegalovirus Infection and Inflammation in Developing Brain. Viruses 13:1078. 2021.
  • Piersma SJ, Brizić I. Natural killer cell effector functions in antiviral defense. FEBS J. 2021.